BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18308844)

  • 41. Effect of angiotensin II on proliferation and differentiation of mouse induced pluripotent stem cells into mesodermal progenitor cells.
    Ishizuka T; Goshima H; Ozawa A; Watanabe Y
    Biochem Biophys Res Commun; 2012 Mar; 420(1):148-55. PubMed ID: 22405822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells.
    Ye P; Nakamura Y; Lalli E; Rainey WE
    Endocrinology; 2009 Mar; 150(3):1303-9. PubMed ID: 18974272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis.
    Yosypiv IV; Schroeder M; El-Dahr SS
    J Am Soc Nephrol; 2006 Apr; 17(4):1005-14. PubMed ID: 16495379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells.
    Romero DG; Plonczynski MW; Gomez-Sanchez EP; Yanes LL; Gomez-Sanchez CE
    Endocrinology; 2006 Aug; 147(8):3889-97. PubMed ID: 16627589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcineurin mediates the angiotensin II-induced aldosterone synthesis in the adrenal glands by up-regulation of transcription of the CYP11B2 gene.
    Yamashiro T; Kuge H; Zhang J; Honke K
    J Biochem; 2010 Jul; 148(1):115-23. PubMed ID: 20413672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus.
    Yoneda T; Takeda Y; Usukura M; Oda N; Takata H; Yamamoto Y; Karashima S; Yamagishi M
    Am J Hypertens; 2007 Dec; 20(12):1329-33. PubMed ID: 18047925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
    Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of adrenal aldosterone production by serine protease prostasin.
    Ko T; Kakizoe Y; Wakida N; Hayata M; Uchimura K; Shiraishi N; Miyoshi T; Adachi M; Aritomi S; Konda T; Tomita K; Kitamura K
    J Biomed Biotechnol; 2010; 2010():793843. PubMed ID: 20204133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.
    Miyoshi T; Otsuka F; Suzuki J; Takeda M; Inagaki K; Kano Y; Otani H; Mimura Y; Ogura T; Makino H
    Biol Reprod; 2006 Jun; 74(6):1073-82. PubMed ID: 16436528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin II-mediated protein kinase D activation stimulates aldosterone and cortisol secretion in H295R human adrenocortical cells.
    Romero DG; Welsh BL; Gomez-Sanchez EP; Yanes LL; Rilli S; Gomez-Sanchez CE
    Endocrinology; 2006 Dec; 147(12):6046-55. PubMed ID: 16973724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels.
    Fujita T; Hirooka K; Nakamura T; Itano T; Nishiyama A; Nagai Y; Shiraga F
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4099-110. PubMed ID: 22661470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cells.
    Vauquelin G; Fierens FL; De Backer JP; Vanderheyden PM
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S15-7. PubMed ID: 9892135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland.
    Sanchez-Lemus E; Murakami Y; Larrayoz-Roldan IM; Moughamian AJ; Pavel J; Nishioku T; Saavedra JM
    Endocrinology; 2008 Oct; 149(10):5177-88. PubMed ID: 18556352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen.
    Sánchez-Lemus E; Benicky J; Pavel J; Larrayoz IM; Zhou J; Baliova M; Nishioku T; Saavedra JM
    Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1376-84. PubMed ID: 19225144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase.
    Condon JC; Pezzi V; Drummond BM; Yin S; Rainey WE
    Endocrinology; 2002 Sep; 143(9):3651-7. PubMed ID: 12193581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Ca(2+)/calmodulin-dependent protein kinase kinase in adrenal aldosterone production.
    Nanba K; Chen A; Nishimoto K; Rainey WE
    Endocrinology; 2015 May; 156(5):1750-6. PubMed ID: 25679868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional interaction of Clock genes and bone morphogenetic proteins in the adrenal cortex.
    Soejima Y; Yamamoto K; Nakano Y; Suyama A; Iwata N; Otsuka F
    Vitam Horm; 2024; 124():429-447. PubMed ID: 38408807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucagon increase after chronic AT
    Mildner M; Müller-Fielitz H; Stölting I; Jöhren O; Steckelings M; Raasch W
    Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):505-518. PubMed ID: 28144709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements.
    Clyne CD; Zhang Y; Slutsker L; Mathis JM; White PC; Rainey WE
    Mol Endocrinol; 1997 May; 11(5):638-49. PubMed ID: 9139807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.